Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report

ConclusionsImmune checkpoint inhibitors should be avoided in allograft recipients but high-intensity immunosuppression is effective to salvage allograft rejection induced by these agents.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research